SCHEMBL5230201

SCHEMBL5230201

COc1cc(-c2cc(Cl)cnc2OC)ccc1[CH]C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.45
FGFR1 P11362 1/20 0.42
FGFR2 P21802 1/20 0.42
FGFR3 P22607 1/20 0.42
SCN9A Q15858 2/20 0.40
SCN5A Q14524 1/20 0.40
RELA Q04206 1/20 0.39
METAP2 P50579 1/20 0.38
FYN P06241 3/20 0.38
PIK3CG P48736 1/20 0.38
BACE1 P56817 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
CHEK1 O14757 1/20 0.37
CHEK2 O96017 1/20 0.37
MAPT P10636 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
ERN1 O75460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230209 0.74 FFAR4 (0.40) FFAR4SCN9ASCN5AMETAP2FYN
SCHEMBL2009544 0.74 FFAR4 (0.40) FFAR4SCN9ASCN5AMETAP2FYN
SCHEMBL5231977 0.71 FFAR4 (0.42) FFAR4MKNK1MKNK2
SCHEMBL4978221 0.70 FFAR4 (0.48) FFAR4METAP2GPBAR1MAPT
SCHEMBL16194553 0.69 FFAR4 (0.45) FFAR4FGFR1FGFR2FGFR3SCN9A
SCHEMBL12611466 0.69 NNMT (0.46) FFAR4GPBAR1MKNK1MKNK2CSF1R
SCHEMBL2004116 0.68 FFAR4 (0.46) FFAR4SCN9ASCN5AMETAP2BACE1
SCHEMBL27780041 0.68 FFAR4 (0.46) FFAR4SCN9ASCN5AMETAP2BACE1
SCHEMBL4970482 0.68 SQOR (0.45) FFAR4SCN9ARELAGPBAR1CHEK1
SCHEMBL10475005 0.67 FFAR4 (0.41) FFAR4SCN9ASCN5AGPBAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor N.V. ORGANON (NL) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor NR3C1, NR3C2, MC2R FFAR4 84/4885FGFR1 259/4885FGFR2 685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.